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1. Introduction 
The glycoprotein cY1-antitrypsin (al-AT) is the 
major inhibitor of proteolytic enzymes in human 
plasma [I]. It has been purified from several species 
including man [2] and rat [3]. The molecular weight 
of rat al-AT is about 50 000. a,AT Deficiency is 
associated with pulmonary disease (emphysema) in 
man and in some cases with liver disease. In patients 
with al-AT deficiency there is an accumulation of 
cu,-AT in the endoplasmic reticulum due to defective 
secretion of the protein [4] with frequent distension 
of the cisternal space by globules of precipitated 
cwl-AT. Agarose electrophoresis of human intrahepatic 
(yl -AT reveals fractions with a more cathodal mobility 
as well as one identical to plasma ol,-AT [5]. The 
cathodal fractions possibly correspond to complex 
formation with intrahepatic proteolytic enzymes, the 
presence of a propeptide similar to that reported for 
albumin, or incompletely glycosylated protein species. 
These observations suggest hat a study of the biosyn- 
thesis of al-AT may be of interest with respect to the 
pathogenesis of liver disease associated with al-AT 
deficiency. In this paper cell-free translation of rat 
liver mRNA and isolation of the al-AT translation 
product are reported as is the partial amino acid 
sequence of its signal or prepeptide. 
2, Materials and methods 
Tritiated amino acids and [35S]methionine of the 
highest available specific activity were obtained from 
the Radiochemical Centre, Amersham. Oligo (dT)- 
cellulose (type 2) was from Collaborative Research 
Inc., and Enhance@ from New England Nuclear. 
Abbreviations: q-AT, a,-antitrypsin; SDS, sodium dodecyl 
sulphate; PTH, phenylthiohydantoin; PAGE, polyacrylamide 
gel electrophoresis 
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Chemicals for the sequenator were obtained from 
Rathburn Chemicals. Guanidinium thiocyanate 
@rum) was from Fluka. Protein A Sepharose was 
from Pharmacia. All other chemicals were reagent 
grade. 
Rat al-AT was purified using a modification of the 
procedure described for human al-AT [2, to be pub- 
lished]. The purified protein migrated as a single band 
on SDS-PAGE in both reduced and unreduced form 
(fig.l), and was quantitatively complexed by added 
Fig.1. SDS-PAGE (disc) of purified rat plasma q-AT. 
About 10 pg was applied to each gel. Left, sample reduced 
with 2-mercaptoethanol prior to electrophoresis; right, 
unreduced sample. 
297 
Volume 130, number 2 PEBS LETTERS August 198 1 
trypsin. Rabbits were immunized with or-AT emulsi- 
fied with Freund’s complete adjuvant. The immuno- 
globulin fraction of the antiserum was eluted in 50 mM 
Tris buffer, pH 7.2, from a DEAE-Sephadex A-50 
column. 
Messenger RNA from rat liver was prepared accord- 
ing to the method of Chirgwin et al. [6], using 50% 
instead of 75% ethanol in the first precipitation step. 
Poly(A)-containing RNA was obtained by chromatog- 
raphy on oligo(dT)-cellulose, again using the condi- 
tions of Chirgwin et al. [6]. RNA was quantitated 
using Bism at 260 nm of 200. 
In vitro translation of RNA was performed in a 
rabbit reticulocyte lysate treated with staphylococcal 
nuclease according to Pelham and Jackson [7]. Incu- 
bations were for 90 min at 35°C. Total incorporation 
of isotope into proteins was estimated by liquid scin- 
tillation measurements after trichloroacetic acid pre- 
cipitation of a small aliquot of the incubate on filter 
paper. Translation products were also analysed by 
SDS-PAGE using 1 O-l 5% gradient slab gels. Unstain- 
ed gels were dried and autoradiography using fluorog- 
raphic enhancement [8] was performed at -70°C 
for 2-5 days. 
Immunoprecipitation of the cur-AT translation 
product was performed in 1% NP-40 buffer according 
to Dobberstein et al. [9]. &i-AT was eluted from the 
protein A Sepharose with 1% SDS. Sperm whale 
myoglobin (300 nmol) was added as carrier and pro- 
teins were precipitated by the addition of five volumes 
of acetone containing 0.1 M HCl. After incubation 
overnight at 22°C and centrifugation, the precipitate 
was dissolved in 0.4 ml formic acid. It was then sub- 
jected to automated Edman degradations in a Beckman 
890 C sequenator using the 1 M quadrol program as 
described previously [IO]. The degradation products 
were evaporated to dryness, dissolved in methanol 
and the radioactivity was measured in a Packard liquid 
scintillation spectrometer. Rat plasma al-AT was 
degraded by the same procedure and PTH-derivatives 
were identified by high pressure liquid chromatog- 
raphy [I I]. 
3. Results and discussion 
al-AT is an acute-phase reactant protein with 
2-3 fold increases in plasma concentration due to an 
increased rate of synthesis after tissue injury. We 
therefore treated rats with subcutaneous injections of 
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turpentine 24 h prior to sacrifice to increase the intra- 
hepatic concentration of a, -AT mRNA. As rat livers 
are rich in ribonuclease, we adopted the method of 
Chirgwin et al. in which tissue homogenisation is 
performed in guanidinium thiocyanate containing 
fV-lauroyl sarcosine and 2-mercaptoethanol which 
ensures rapid and complete protein denaturation. 
With this method 0.1-0.5 mg of polyadenylated 
RNA was obtained per gram of liver. The Eg6a to 
EZgO ratio of the final product was greater than 2.07. 
The rat liver mRNA effectively stimulated protein 
synthesis in the reticulocyte lysate. Optimal stimula- 
tion was obtained with approximately 40 pug poly(A)- 
RNA per ml. The antiserum against err -AT was mono- 
specific and well suited for immunoprecipitation of 
&,-AT from the translation mixtures (fig.2). The addi- 
tion of anti-or-AT to the translation did not signifi- 
cantly increase the incorporation of labelled amino 
acids into pre or-AT in contrast to what has been 
Fig.2 lluoro~am of SDS-PAGE of peptides obtained by 
cell-free synthesis in a rabbit reticulocyte lysate using rat 
liver mRNA (left). The product immunoprecipitated with a 
monospecific antiserum against rat a,-AT is shown to the 
right. 
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reported for some other proteins whose translation 
products have had low solubility [ 121. Addition of 
increasing amounts of purified rat plasma @,-AT to 
the incubates prior to immunoprecipitation succes- 
sively displaced the labelled al-AT from the anti- 
bodies. The apparent molecular weight of the reduced 
and alkylated translation product was 45 000 as 
judged from the SDS-PAGE whereas that of reduced 
rat plasma CY~-AT was approximately 52 000. The 
difference in molecular weights is explained by the 
total lack of carbohydrate in the translation product. 
For sequence analysis of the in vitro translation 
products incubations of 0.25-l .O ml were used. 
Translations with [ 3H] leucine and [ 3H] isoleucine 
have been performed. SDS-PAGE of the immuno- 
precipitated [3H]leucine translation product showed 
that 88% of the radioactivity was in the &,-AT band. 
This step was therefore judged unnecessary and the 
washed immunoprecipitates were eluted in 1% SDS, 
directly precipitated with acetone containing 0.1 M 
HCl after addition of carrier myoglobin, dissolved in 
formic acid and subjected to sequenator degradation. 
The results of the degradations are shown in fig.3. 
The background radioactivity was fairly high in the 
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Fig.3. Automated Edman degradation of rat q-AT synthe- 
tized in the rabbit reticulocyte lysate with [3H]leucine and 
[ 3H]isoleucine. The a,-AT was immunoprecipitated as 
described in section 2. The numbers over the histogram indi- 
cate the positions where identification of the radioactive 
ammo acid was regarded positive. The dotted line is an 
hypothetical curve for a degradation with 93.5% repetitive 
yield. 
leucine degradation but low in the isoleucine degrada- 
tion. As calculated from the sequenator un of [3H]- 
leucine labelled o(r -AT an approximate repetitive 
yield of 93.5% was obtained. Assignments of isoleucine 
in position 4 and leucine in positions 8,9,10,11,14,17 
and possibly 22 could be made. Analysis of the PTH 
derivatives of plasma &i-AT after sequenator degrada- 
tion gave the amino-terminal sequence: Glu, Asp, Ala, 
Gln, Glu, Arg, Asp, Arg. Since there are no leucine or 
isoleucine residues in the amino-terminal part of 
plasma al-AT, no alignment in an overlapping segment 
has been possible. The length of the signal peptide 
thus remains unknown. 
The results suggest hat the cur-AT pre-peptide con- 
tains clusters of hydrophobic residues in similarity to 
other pre-peptides equenced [ 131. Like both bovine 
and rat pre-proalbumin pre al-AT has a block of four 
adjacent leucine residues [ 141. A closer comparison 
with other prepeptides must await the competition 
of the sequence of the (Y,-AT pre-peptide. 
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